Genetic disruption of the oncogenic HMGA2–PLAG1–IGF2 pathway causes fetal growth restriction
Walid Abi Habib(Sorbonne Université), Irène Netchine(Inserm), Tony Yuen(Icahn School of Medicine at Mount Sinai), Jennifer Ben Salem, Yves Le Bouc(Inserm), Anne Lienhardt-Roussie(Centre Hospitalier Universitaire de Limoges), Thomas Édouard(Université Toulouse III - Paul Sabatier), Salah Azzi(Inserm), Frédéric Brioude(Inserm), Madeleine D. Harbison(NewYork–Presbyterian Hospital), Frédérique Tixier(Hôpital Debrousse), James T. Bennett(University of Washington)
Cited by 137
Related Papers
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
|Nature|1998|2.4k
Child Health, Developmental Plasticity, and Epigenetic Programming
|Endocrine Reviews|2010|625
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
|Nature Reviews Endocrinology|2018|596
Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue
|Proceedings of the National Academy of Sciences|2000|580